Johnson & Johnson’s Biosense Webster today announced the first cases with its investigational Omnypulse catheter as part of the Omny-IRE clinical trial. The Omnypulse platform features the Omnypulse catheter and the Trupulse generator. Omny-IRE looks at the platform for mapping and treatment of symptomatic paroxysmal AFib during standard ablation procedures. Dr. Dr. Mattias Duytschaever performed […]
Johnson & Johnson MedTech
What are the largest medical device companies?
Medtronic, Johnson & Johnson MedTech and Siemens Healthineers again lead the Medtech Big 100 list of largest medical device companies. However, there is so much more to Medical Design & Outsourcing and MassDevice‘s 2023 edition of the Medtech Big 100 report. We pulled thousands of data points to provide information on annual revenue, R&D spending, […]
Johnson & Johnson finalizes Kenvue spilt-off
Johnson & Johnson announced today that it completed the separation of its Kenvue consumer health business. Kenvue completed its IPO in May 2023. Johnson & Johnson last month announced its intention to split off at least 80.1% of the shares of Kenvue. The separation enables the company to sharpen its focus on its MedTech and […]
FDA deems latest Abiomed Impella recall Class I
Abiomed, a Johnson & Johnson unit, issued another recall for some of its Impella heart pumps. This marks the third safety notice regarding the heart pumps in as many months. In June, the company recalled 466 Impella 5.5 with SmartAssist devices. Abiomed initiated that recall after receiving complaints relating to purge fluid leaking from the purge […]
The biggest medtech personnel moves so far in 2023
Nearly a quarter of the way through 2023, we’ve seen plenty of movement in the personnel department across medtech. Last July, we broke down the biggest personnel moves in medtech so far in 2022. That was followed up by the full-year report in December. Through more than eight months, the changes atop medtech companies continue […]
FDA approves multiple AFib ablation devices from Biosense Webster
Johnson & Johnson’s Biosense Webster announced today that the FDA approved several products in its cardiac ablation portfolio for zero fluoroscopy workflow. Products that received approval include the ThermoCool SmartTouch SF catheter, the most commonly used ablation catheter for radiofrequency ablation. The portfolio’s approved products also include the standard ThermoCool SmartTouch and Carto Vizigo bi-directional […]
Johnson & Johnson looks to split off Kenvue, focus on MedTech and Pharma
Johnson & Johnson today announced its intention to split off at least 80.1% of the shares of Kenvue. The New Brunswick, New Jersey-based company plans for the separation of its former consumer health business to take place through an exchange offer. Kenvue completed its IPO in May 2023. Through the planned exchange offer, Johnson & […]
J&J’s Biosense Webster launches AFib mapping catheter
Johnson & Johnson’s Biosense Webster announced today that it launched the Optrell mapping catheter with TrueRef technology. Irvine, California-based Biosense Webster designed Optrell as a high-density diagnostic catheter powered by its Carto 3 system. It features small electrodes arranged in a fixed array formation. These provide high-definition electrophysiological mapping of complex cardiac arrhythmia cases. Optrell […]
Johnson & Johnson posts Street-beating Q2, raises guidance
Johnson & Johnson shares are up today on second-quarter results that topped the consensus forecast. Shares of JNJ rose more than 5% to $159.50 apiece in morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly. The New Brunswick, New Jersey-based company posted […]
J&J’s Abiomed recalls Impella again — this time it’s TAVR-related
Johnson & Johnson’s Abiomed unit issued another recall for some of its Impella heart pumps. FDA communications dated July 14 confirmed the second recall in a month for certain Impella products. In June, the company recalled 466 Impella 5.5 with SmartAssist devices. Abiomed initiated that recall after receiving complaints relating to purge fluid leaking from […]
J&J’s Ethicon has a serious Megadyne electrode recall due to potential burns in electrosurgery
The FDA labeled a recall of Megadyne electrode products manufactured by Johnson & Johnson’s Ethicon Class I, the most serious kind. Recalled products include a number of Megadyne Mega Soft electrodes and the Mega 2000 patient return electrode. Ethicon paid an undisclosed amount to acquire Megadyne Medical Products in 2017 after several years of collaboration. […]
